April 29, 2010 / 4:37 PM / in 9 years

J&J to pay over $81 mln in drug case-U.S. Justice

WASHINGTON, April 29 (Reuters) - Two Johnson and Johnson (JNJ.N) subsidiaries have agreed to pay more than $81 million to resolve allegations of illegal promotion of the epilepsy drug, Topamax, the U.S. Justice Department said on Thursday.

It said one unit, Ortho-McNeil Pharmaceutical LLC, has agreed to plead guilty to a misdemeanor and pay a $6.14 million criminal fine for misbranding Topamax in violation of the Food, Drug and Cosmetic Act.

The other unit, Ortho-McNeil-Janssen Pharmaceuticals, will pay more than $75 million to resolve civil allegations under the False Claims Act it illegally promoted Topamax and caused false claims to be submitted to government health care programs, the department said. (Reporting by James Vicini; editing by Andre Grenon)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below